Keyphrases
Kidney Allocation System
100%
Sitravatinib
100%
Migraine Patients
100%
Cerebral Amyloid Angiopathy
100%
Deceased Donor Kidney Transplantation
100%
Registrants
100%
Deceased Donor Transplant
100%
OnabotulinumtoxinA
100%
Chronic Migraine
100%
Procedural
100%
Transplant Rate
100%
Odds Ratio
80%
Pediatric
75%
Headache
65%
Treatment Efficacy
40%
Initial Treatment
40%
Continuation Treatment
40%
Pathophysiology
25%
Immunomodulatory
25%
Autoimmunity
25%
Neurologic
25%
Initiating Treatment
25%
Early Recognition
25%
Early Treatment
25%
Bihemispheric
25%
Older Men
25%
High-dose Methylprednisolone
25%
Routine Clinical Practice
25%
Seizure Activity
25%
Chemotherapy
25%
Microhemorrhage
25%
Tyrosine Kinase Inhibitor
25%
Lobar
25%
Encephalopathy
25%
Vasogenic Edema
25%
Highly Sensitized
25%
Time-to-event Analysis
25%
Washout Period
25%
Cox Proportional Hazards
25%
Access to Transplantation
25%
Interrupted Time Series
25%
Equitable Access
25%
First Impressions
20%
Mainstream Treatment
20%
Retrospective Chart Review
20%
Male Patients
20%
Female Patients
20%
Healthcare Settings
20%
Usual Care
20%
Sex Odds
20%
Medicine and Dentistry
Transplantation
100%
Transformed Migraine
100%
Botulinum Toxin A
100%
Sitravatinib
100%
Kidney Graft
100%
Vascular Amyloidosis
100%
Odds Ratio
80%
Pediatrics
75%
Headache
65%
Isoprenaline
25%
Cohort Effect
25%
Methylprednisolone
25%
Epileptic Seizure
25%
Drug Megadose
25%
Autoimmunity
25%
Pathophysiology
25%
Tyrosine-Kinase Inhibitor
25%
Magnetic Resonance Imaging
25%
Edema
25%
Brain Disease
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Sitravatinib
100%
Botulinum Toxin A
100%
Vascular Amyloidosis
100%
Transformed Migraine
100%
Headache
65%
Chemotherapy
25%
Edema
25%
Brain Disease
25%
Pathophysiology
25%
Protein Tyrosine Kinase Inhibitor
25%
Methylprednisolone
25%